French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1003 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-03

Study Completion Date

2020-07-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since December 2019, a new agent, the SARS-Cov-2 coronavirus has been rapidly spreading from China to other countries causing an international outbreak of respiratory illnesses named COVID-19. In France, the first cases have been reported at the end of January with more than 60000 cases reported since then. A significant proportion (20-30%) of hospitalized COVID-19 patients will be admitted to intensive care unit. However, few data are available for this special population in France.

We conduct a large observational cohort of ICU suspected or proven COVID-19 patients that will enable to describe the initial management of COVID 19 patients admitted to ICU and to identify factors correlated to clinical outcome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France

NCT04420286

Coronavirus Infections COVID19 Outbreak in France

COMPLETED

NOSOcomial COVID-19 in ICU (NOSOCOVID)

NCT04659356

Coronavirus Infectious Disease (COVID-19) Nosocomial Infection Nosocomial COVID-19

UNKNOWN

Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.

NCT04363099

Covid-19

UNKNOWN

Ventilation Associated Pneumonia and Covid-19

NCT05089968

SARS-CoV2 Infection Ventilator Associated Pneumonia Ards +1 more

COMPLETED

Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit

NCT04355481

Covid-19 Viral Infection

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia, Viral Critically Ill Corona Virus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Suspected or proven COVID-19 critically ill patients

No intervention

Intervention Type OTHER

No intervention

Control

No intervention

Intervention Type OTHER

No intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted to ICU for suspected or proven SARS-Cov-2 infection, defined by positive SARS-Cov-2 PCR or CT scan images
* Patient \> or= 18 years

Exclusion Criteria

* Patient study refusal
* Patient already enrolled in the present study
* Patient with respiratory illness with negative COVID-19 CT scan images and negative COVID\_19 PCR

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No